+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Serological and clinical studies of epstein barr virus infection in allogeneic marrow graft recipients



Serological and clinical studies of epstein barr virus infection in allogeneic marrow graft recipients



Journal of Cellular Biochemistry Suppl. (14 Part A): 312




Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 033353690

Download citation: RISBibTeXText


Related references

Serological And Molecular Studies Of Epstein-Barr Virus Infection In Allogeneic Marrow Graft Recipients. Transplantation 49(4): 725-730, 1990

Serological and molecular studies of epstein barr virus infection in allogenic marrow graft recipients. Transplantation 49(4): 725-730, 1990

Effect of combined T- and B-cell depletion of allogeneic HLA-mismatched bone marrow graft on the magnitude and kinetics of Epstein-Barr virus load in the peripheral blood of bone marrow transplant recipients. Clinical Transplantation 18(5): 518-524, 2004

Epstein-Barr virus infection in bone marrow transplantation recipients. Blood 92(10 Suppl. 1 Part 1-2): 338B, Nov 15, 1998

Epstein-Barr virus infection and immunity in bone marrow transplant recipients. Transplantation 42(1): 50-54, 1986

Serological and clinical findings in patients with serological evidence of reactivated Epstein-Barr virus infection. Apmis 104(6): 424-428, 1996

Epstein-Barr virus infection in sixty pediatric liver graft recipients: diagnosis of primary infection and virologic follow-up. Pediatric Infectious Disease Journal 18(8): 698-702, 1999

Natural killer cells and cytomegalovirus and Epstein-Barr virus infection in cardiac graft recipients. Cor et Vasa 30(6): 435-441, 1988

Treatment with ganciclovir and Ig for acute Epstein-Barr virus infection after allogeneic bone marrow transplantation. Blood 82(7): 2257-2258, 1993

Primary Epstein-Barr virus infection with pneumonia transmitted by allogeneic bone marrow after transplantation. Clinical Infectious Diseases 43(7): 892-895, 2006

Epstein-Barr virus infection in allogeneic marrow grafting: lessons for transplant physicians and virologists. Annals of Hematology 64(Suppl.): A162-A165, 1992

Epstein-Barr virus DNA load kinetics analysis in allogeneic hematopoietic stem cell transplant recipients: Is it of any clinical usefulness?. Journal of Clinical Virology 97: 26-32, 2017

Post-transplant plasmacytoma without Epstein-Barr virus infection occurring rapidly after unrelated allogeneic bone marrow transplantation. International Journal of Hematology 88(5): 606-609, 2008

Low risk of Epstein-Barr virus -associated post-transplant lymphoproliferative disease in patients receiving elutriated allogeneic marrow transplants may reflect depletion of EBV infected lymphocytes from the graft. Blood 86(10 Suppl. 1): 626A, 1995

Establishment of epstein barr virus nuclear antigen expressing cell lines by infection of epstein barr virus genome negative human lymphoma cells with different epstein barr virus strains. International Journal Of Cancer: 161-166, 1976